MedPath

Moderate Sedation Combined With Acupuncture Anesthesia in Gastroscopy and Colonoscopy on Screening Research

Not Applicable
Completed
Conditions
Gastrointestinal Endoscopy
Interventions
Procedure: eletroacupuncture(transcutaneous electrical acupuncture point stimulation )
Drug: placebo needle
Registration Number
NCT05485064
Lead Sponsor
The Affiliated Hospital of Qingdao University
Brief Summary

The purpose of this study is mainly about the feasibility and rationality of moderate sedation combined with acupuncture anesthesia in the application of gastroscopy and colonoscopy ,Then we evaluate the effectiveness and advantages of the combination of acupuncture anesthesia and drug anesthesia.

Detailed Description

With the increase of the proportion of the patients who crave for performing painless gastroscopy and colonoscopy in recent years, it is crucial to seek a more secure and effective method of anesthesia or sedation. At present, the universal anesthetic method on gastroscopy and colonoscopy in China is the general anesthesia without intubation which usually uses propofol and opioid analgesics,Although the satisfaction of patients is high, the incidence of anesthesia-related complications and drug-related adverse reactions is high .The incidence of adverse events during the gastroscopy and colonoscopy is high, and the medical expense of anesthesia is high. At present, more than 2/3 of the patients undergo painless gastroscopy or colonoscopy are middle-aged and elderly patients, so the overdose which prolongs the recovery time、discharge time of patients and reduces the recovery quality of patients is common. The moderate sedation, which fundmentally does not affect hemodynamics、autonomous respiration and protective reflexes, is incomparable to general anesthesia . And acupuncture anesthesia also acts as a safe anesthetic method can provide safer analgesic effect.Theoretically,the combination of both of them is a relatively perfect and safe painless method.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
108
Inclusion Criteria
  1. Outpatients
  2. Patients with ASA grade I-III
  3. A sufficient level of education to understand study procedures and can communicate with investigators.
Exclusion Criteria
  1. Patients with serious systemic diseases such as severe cardiopulmonary disease or hepatic diseases or renal diseases.

  2. Patients under the age of 18.

  3. Patients who did not sign the informed consent form.

  4. Patients who have a history of alcohol abuse or drug abuse.

  5. People who are allergic to anesthetic related ingredients, such as soybeans, eggs and so on.

  6. Patients with extreme fear or anxiety about acupuncture.

  7. Patients with relative contraindications of gastrointestinal endoscopy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
electroacupuncture(transcutaneous electrical acupuncture point stimulation )and remimazolameletroacupuncture(transcutaneous electrical acupuncture point stimulation )The investigator 1 combine electroacupuncture(transcutaneous acupoint electrical stimulation ) with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy.
placebo needle and remimazolamplacebo needleThe investigator 1 combine placebo needle with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy.
fentanyl and remimazolamfentanylThe investigator 1 combine fentanyl with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy.
electroacupuncture(transcutaneous electrical acupuncture point stimulation )and remimazolamremimazolamThe investigator 1 combine electroacupuncture(transcutaneous acupoint electrical stimulation ) with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy.
placebo needle and remimazolamremimazolamThe investigator 1 combine placebo needle with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy.
fentanyl and remimazolamremimazolamThe investigator 1 combine fentanyl with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy.
Primary Outcome Measures
NameTimeMethod
patient satisfaction with sedation instrument,PSSIDuring gastroscopy and colonoscopy

The investigator 2 needs to use VAS scores to evaluate satisfaction about sedation feeling when they accepted gastroscopy and colonoscopy .The score ranges from 0 to10 and need patients evaluate it by themself when the gastroscopy or colonoscopy were finished.The score from 0 (extremely dissatisfied)to 10(extremely satisfied).

clinical satisfaction with sedation instrument,CSSIDuring gastroscopy and colonoscopy

The investigator 2 needs to use VAS scores to evaluate satisfaction about doctors when they carry out the operation.The score from 0 (extremely dissatisfied)to 10(extremely satisfied).

patient's pain scoreDuring gastroscopy and colonoscopy

The investigator 2 needs to use VAS scores to evaluate patients' pain score .The score from 0 (extremely dissatisfied)to 10(extremely satisfied).

Secondary Outcome Measures
NameTimeMethod
respiratory ratebefore gastrointestinal endoscopy、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy

The investigator 2 needs to record respiratory rate(for example 15 times/min)before gastrointestinal endoscopy 、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(tachypnea:respiratory rate is more than 20 times/min;bradypnea:respiratory rate is less than 12 times/min)

operation time about gastrointestinal endoscopyDuring gastroscopy and colonoscopy

The investigator 2 needs to record operation time about gastrointestinal endoscopy.

heart ratebefore gastrointestinal endoscopy、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy

The investigator 2 needs to record heart rate(for example 60 times/min)before gastrointestinal endoscopy 、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(tachycardia:heart rate is more than 100 times/min;bradycardia:heart rate is less than 60 times/min)

pulse oximetrybefore gastrointestinal endoscopy、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy

The investigator 2 needs to record pulse oximetry (for example 97% )before gastrointestinal endoscopy 、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(hypoxemia:pulse oximetry is lower than 90%)

systolic pressure 、diastolic pressurebefore gastrointestinal endoscopy、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy

The investigator 2 needs to record systolic pressure 、diastolic pressure(for example 120/75mmHg ) before gastrointestinal endoscopy 、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(hypertension:systolic pressure ≥140mmHg or diastolic pressure ≥90mmHg;hypotension:systolic pressure ≤90mmHg or diastolic pressure ≤60mmHg)

the extent of cardia exposureDuring gastroscopy and colonoscopy

The investigator 2 needs to record the extent of cardia exposure to evaluate these interventions'effect on gastroscopy ,the investigator 2 use the table of the extent of preventriculus exposure(score from 1 to 4,1=the extent of exposure lower than 25%;2=the extent of exposure between 25% and 50%;3=the extent of exposure between 50%and 75%;4=the extent of exposure between 75%and 100%)

adverse reactionsDuring gastroscopy and colonoscopy

The investigator 2 needs to record the adverse reactions such as nausea、emesis, salivation, restlessness, and breath holding to analyze efficacy of relate treatment.

patient's recovery timeThe end of gastroscopy and colonoscopy

The investigator 2 needs to record to evaluate patient's recovery quality about patients

patient's departure timeThe end of gastroscopy and colonoscopy

The investigator 2 needs to record patient's departure time to evaluate recovery quality about patients

time to resume normal operationThe end of gastroscopy and colonoscopy

The investigator 2 needs to record the time to resume normal operation about patient

Trial Locations

Locations (1)

Jixiangyu

🇨🇳

Qingdao, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath